These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 30949516)
1. The APOE Pouwer MG; Heinonen SE; Behrendt M; Andréasson AC; van Koppen A; Menke AL; Pieterman EJ; van den Hoek AM; Jukema JW; Leighton B; Jönsson-Rylander AC; Princen HMG J Diabetes Res; 2019; 2019():9727952. PubMed ID: 30949516 [TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice. Adingupu DD; Heinonen SE; Andréasson AC; Brusberg M; Ahnmark A; Behrendt M; Leighton B; Jönsson-Rylander AC J Diabetes Res; 2016; 2016():8630961. PubMed ID: 27774459 [No Abstract] [Full Text] [Related]
3. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice. Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice. Wong MC; van Diepen JA; Hu L; Guigas B; de Boer HC; van Puijvelde GH; Kuiper J; van Zonneveld AJ; Shoelson SE; Voshol PJ; Romijn JA; Havekes LM; Tamsma JT; Rensen PC; Hiemstra PS; Berbée JF Atherosclerosis; 2012 Feb; 220(2):362-8. PubMed ID: 21798539 [TBL] [Abstract][Full Text] [Related]
5. Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE Venegas-Pino DE; Lagrotteria A; Wang PW; Morphet J; Clapdorp C; Shi Y; Werstuck GH Atherosclerosis; 2018 Aug; 275():88-96. PubMed ID: 29879686 [TBL] [Abstract][Full Text] [Related]
6. The Prebiotic Inulin Aggravates Accelerated Atherosclerosis in Hypercholesterolemic APOE*3-Leiden Mice. Hoving LR; de Vries MR; de Jong RCM; Katiraei S; Pronk A; Quax PHA; van Harmelen V; Willems van Dijk K Nutrients; 2018 Feb; 10(2):. PubMed ID: 29401645 [TBL] [Abstract][Full Text] [Related]
7. The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice. Hoving LR; Katiraei S; Pronk A; Heijink M; Vonk KKD; Amghar-El Bouazzaoui F; Vermeulen R; Drinkwaard L; Giera M; van Harmelen V; Willems van Dijk K Sci Rep; 2018 Nov; 8(1):16515. PubMed ID: 30409998 [TBL] [Abstract][Full Text] [Related]
8. Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice. Gorman T; Hope DC; Brownlie R; Yu A; Gill D; Löfvenmark J; Wedin M; Mayers RM; Snaith MR; Smith DM Diabetes Obes Metab; 2008 Sep; 10(10):885-97. PubMed ID: 18034843 [TBL] [Abstract][Full Text] [Related]
9. A Common Gene Variant in Glucokinase Regulatory Protein Interacts With Glucose Metabolism on Diabetic Dyslipidemia: the Combined CODAM and Hoorn Studies. Simons N; Dekker JM; van Greevenbroek MM; Nijpels G; 't Hart LM; van der Kallen CJ; Schalkwijk CG; Schaper NC; Stehouwer CD; Brouwers MC Diabetes Care; 2016 Oct; 39(10):1811-7. PubMed ID: 27660121 [TBL] [Abstract][Full Text] [Related]
10. Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP mice. Auvinen HE; Wang Y; Princen H; Romijn JA; Havekes LM; Smit JW; Meijer OC; Biermasz NR; Rensen PC; Pereira AM PLoS One; 2013; 8(5):e63882. PubMed ID: 23717502 [TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. Hinder LM; Vincent AM; Hayes JM; McLean LL; Feldman EL Exp Neurol; 2013 Jan; 239():102-10. PubMed ID: 23059459 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes. Baker DJ; Atkinson AM; Wilkinson GP; Coope GJ; Charles AD; Leighton B Br J Pharmacol; 2014 Apr; 171(7):1629-41. PubMed ID: 24772483 [TBL] [Abstract][Full Text] [Related]
13. Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice. de Vries-van der Weij J; Zadelaar S; Toet K; Havekes LM; Kooistra T; Rensen PC Atherosclerosis; 2009 Sep; 206(1):153-8. PubMed ID: 19345354 [TBL] [Abstract][Full Text] [Related]
14. Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes. Baker DJ; Wilkinson GP; Atkinson AM; Jones HB; Coghlan M; Charles AD; Leighton B Br J Pharmacol; 2014 Apr; 171(7):1642-54. PubMed ID: 24772484 [TBL] [Abstract][Full Text] [Related]
15. Atherosclerotic dyslipidemia revealed by plasma lipidomics on ApoE Chen Y; Wen S; Jiang M; Zhu Y; Ding L; Shi H; Dong P; Yang J; Yang Y Atherosclerosis; 2017 Jul; 262():78-86. PubMed ID: 28527370 [TBL] [Abstract][Full Text] [Related]
16. CETP expression reverses the reconstituted HDL-induced increase in VLDL. Wang Y; Berbée JF; Stroes ES; Smit JW; Havekes LM; Romijn JA; Rensen PC J Lipid Res; 2011 Aug; 52(8):1533-41. PubMed ID: 21606464 [TBL] [Abstract][Full Text] [Related]
17. A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice. Fujii A; Allen TJ; Nestel PJ Atherosclerosis; 2007 Jul; 193(1):55-61. PubMed ID: 16996521 [TBL] [Abstract][Full Text] [Related]
18. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036 [TBL] [Abstract][Full Text] [Related]
19. Impaired GK-GKRP interaction rather than direct GK activation worsens lipid profiles and contributes to long-term complications: a Mendelian randomization study. Wang K; Shi M; Luk AOY; Kong APS; Ma RCW; Li C; Chen L; Chow E; Chan JCN Cardiovasc Diabetol; 2024 Jun; 23(1):228. PubMed ID: 38951793 [TBL] [Abstract][Full Text] [Related]